INTRODUCTION
Cervical erosion is a common condition seen in most women of all the age groups. About 85% women suffer from the cervical erosion i.e. benign condition of female genital tract during their lifetime.
[1] It is asymptomatic in initial stage but later on it progresses to show many symptoms like white discharge, itching vulva, dyspareunia etc. It adversely affects the physiological and psychological health of women and even interferes in their professional life. It may even lead to infertility. [2] It can show malignant changes in chronic stage. [3] Cervical cancer is one of the most common cancers in women worldwide with about 5,28,000 new cases in 2012 resulting in 2,66,000 deaths from cervical cancer worldwide in 2012, accounting for 7.5% of all female cancer deaths. Almost nine in ten (87%) cervical cancer deaths occur in less developed regions. [4] Cervical cancer is ranked as the most frequent cancer in women in India. The current estimates indicate approximately 132,000 new cases diagnosed and 74,000 deaths annually in India; accounting to nearly 1/3 rd of the global cervical cancer deaths. [5] High-quality screening with cytology (Pap smear) has markedly reduced mortality from squamous cell cervical cancer, which comprises 80% to 90% of cervical cancers. Cytology (Pap test) screening has been very successful in lowering cancer incidence and mortality in countries where goodquality screening is available.
[6]
While going through the Ayurvedic literature it becomes evident that all the gynaecological disorders are included in Yonivyapad and Streeroga. Direct reference regarding the cervical pathology cannot be traced in Ayurvedic Classics. However, considering the pathology and main symptoms of that is discharge and erosion, it can be correlated with Garbhashayagrivagata Vrana. The present study is aimed to find out a method of treatment, which was impart a permanent, easy, effective cure and was with normal side effect, which was accepted by the patient. Some of the drugs like Darvi (Barberies aristata DC.), Lodhra (Symplocos recemosa Roxb.), Haridra (Curcuma longa Linn), Sphatika (alum) and Gairika (red ochre) has been mentioned in Upadansha Chikitsa [7] were selected for Yoni Varti (vaginal suppository 
OBJECTIVES OF THE STUDY
To evaluate the efficacy of Darvyadi Yoni Varti on cervical erosion.
MATERIALS AND METHODS
It was an open label single arm clinical study conducted at Streeroga and Prasutitantra Out Patient Department (OPD), I.P.G.T. and R.A. Jamnagar.
Patients
Patients (N=43) attending the out patient department of Prasutitantra and Streeroga, fulfilling the criteria for the selection were selected for the study. A detailed history was taken according to the proforma specially prepared for this purpose.
Drugs
The raw drugs of Yoni Varti (vaginal suppository) were collected from the Pharmacy of Gujarat Ayurved University and authenticated in the Pharmacognosy Laboratory, I.P.G.T. and R.A. Jamnagar. Vaginal suppository was prepared in the department of Rasashashtra and Bhaishajya Kalpana. Table 1 shows the ingredients of Yoni Varti. 
Ethical clearance
The study was cleared by the Institutional Ethics 
Inclusion criteria
Married patients of aged between 20 to 60 years with clinical signs and symptoms of cervical cell pathology including white discharge, contact bleeding, backache, erosion, hypertrophy, Acute and Chronic Cervicitis, Cervical intraepithelial neoplasia (CIN) I and II (As per CIN classification) in Pap smear test were enrolled in the study.
Exclusion criteria
Patients with Tuberculosis of uterus, Procedentia, CIN Grade III (As per Bethesda classification), TB, DM, S.T.D., H.I.V., Pregnant and lactating women, aged <20 and > 60 years were excluded from study.
Posology
The treatment protocol comprised of Darvyadi Yoni Varti of 3 gm once at bed time for 21 days. The assessment was done with subjective criteria and papsmear after 45 days.
Criteria for assessment
Assessment was done on the basis of improvement in signs and symptoms of the disease, Changes in Pap smear report, improvement in other investigatory parameters. A special scoring pattern was adopted for the signs and symptoms.
OBSERVATION AND RESULTS
In this clinical study, total 43 patients were registered, out of which 41 patients completed the treatment, whereas two patients discontinued. In the present study, maximum number of patients, i.e. 41.86% belonged to age group of 20-30 years, 46.51% were from lower middle class, 53.49% were multipara, 62.79% were from rural area, 100% had Yoni Srava (vaginal discharge) and 41.86% had been suffering for 1-2 year.
Pap-smear report shows that 24 patients had chronic cervicitis while 7 patients had acute cervicitis, 7 had acute on chronic cervicitis, 3 had benign hypertrophy and 1 patient had CIN-1 respectively. Table 3 shows the statistically highly significant relief in the % area of cervical erosion and appearance in per speculum finding.
Effect of therapy on cytology reports shows after treatment normal cytology was observed in 6 patients of chronic cervicitis, 3 patients of acute cervicitis, 1 patient of acute on chronic cervicitis and 2 patients of benign hypertrophy. Decrease in infection with repair changes was observed in 10 patients of chronic cervicitis, 3 patients of acute cervicitis, 5 patients of acute on chronic cervicitis. No change was observed in 5 patients of chronic cervicitis, 1 patient of acute cervicitis. Infection was increased in 3 patients of chronic cervicitis, 1 patients of benign hypertrophy and 1 patient of normal cytology report. (Table 4 )
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In the present study, majority of patients i.e. 41.86% 30 years which indicates that this disease is common problem of reproductive life. The sexual life is most active during this period making the genitals more prone to infect laceration causing cervical cell pathology. 46.51% were from lower middle class. The increased risk with low socioeconomic status is attributed to a lack of screening, failure to treat precancerous conditions, and lack of knowledge about prevention papilloma virus (HPV) infection. multipara which progressive rise of dysplasia with increasing parity. Previous most of studies documented multiparity as a risk factor. 62.79% were from rural area which reveals that nutriti hygiene are the most crucial factors responsible for preventing vaginal. 41.86% had been suffering for 1 year. Chronicity of a disease provides knowledge of its severity and is helpful to decide the prognosis of the disease. Patients do not consul creates major vaginal discomfort or other associated problems like severe backache, bodyache, burning micturition, infertility etc. So, this negligence converts the disease into chronic state.
Result was observed highly statistical most symptoms. Properties of Tridoshashamaka, Shothahara Kandughna normalized symptoms. Abnormal vaginal discharge, pruritus vulvae is mainly due to trichomonas, monilial an bacterial infection which is reduced by drugs due to its Antipyretic, Anti protozoal, Antimicrobial, Anti inflammatory and Antifungal action. [12], [13] by which it kills the causative microorganism, reduces inflammation and also supports the vaginal defense mechanism.
Probable mode of action of

CONCLUSION
The present study is aimed to find out a method of treatment, which was impart a permanent, easy, effective cure and was with normal side effect, which was accepted by the patient. The study is overall concluded that the Darvyadi Yoni Varti is highly effective in reducing subjective and objective variables of Garbhashaya Mukhagata Vrana (cervical erosion) and will also help in deriving new conclusion and axioms in the management of Garbhashaya Mukhagata Vrana (cervical erosion). No Adverse Drug Reaction (ADR) and side effects were reported in the present study.
